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Autotransporter (AT) proteins are the largest class of
extracellular virulence proteins secreted from Gram-
negative bacteria. The mechanism by which AT
proteins cross the bacterial outer membrane (OM),
in the absence of ATP or another external energy
source, is unknown. Here we demonstrate a linear
correlation between localized regions of stability
(DGfolding) in the mature virulence protein (the AT
‘‘passenger’’) and OM secretion efficiency. Destabi-
lizing the C-terminal b-helical domain of a passenger
reduced secretion efficiency. In contrast, destabiliz-
ing the globular N-terminal domain of a passenger
produced a linearly correlated increase in secretion
efficiency. Thus, C-terminal passenger stability facil-
itates OM secretion, whereas N-terminal stability
hinders it. The contributions of regional passenger
stability to OM secretion demonstrate a crucial role
for the passenger itself in directing its secretion, sug-
gesting a novel type of ATP-independent, folding-
driven transporter.
INTRODUCTION
Gram-negative bacterial infections lead to diverse human
diseases, including bacterial meningitis, dysentery, whooping
cough, peptic ulcers, pneumonia, peritonitis, and cholera. Like
all pathogenic bacteria, Gram-negative pathogens must secrete
a wide variety of proteins to the outer bacterial surface, where
these proteins perform crucial functions for the attachment to,
recruitment of essential nutrients from, and invasion and dis-
abling of mammalian host cells. Gram-negative bacteria use at
least seven distinct mechanisms for secretion of proteins across
the outer membrane (OM), but the most common OM secretion
mechanism is autotransporter (AT; also known as Type Va)
secretion. The AT secretion mechanism was originally named
to reflect the apparently independent OM secretion behavior of
AT proteins: when placed in a heterologous Gram-negativeChemistry & Biology 19, 287host, most AT genes are readily expressed and the encoded
protein transported to the extracellular milieu, suggesting
minimal reliance on host-specific factors to facilitate OM trans-
port (Loveless and Saier, 1997). Each AT is synthesized as
a tripartite preprotein containing an N-terminal signal sequence
that directs secretion across the inner membrane, a central
‘‘passenger’’ that represents the mature extracellular virulence
protein, and a C-terminal OM porin (the ‘‘b-domain’’) that is
essential for OM transport. AT passengers have highly diverse
sequences, lengths, and functions, but almost all are predicted
to contain b-helical structure (Kajava et al., 2001; Junker et al.,
2006). Although it was originally proposed that an AT protein
autonomously catalyzes transport of its own passenger across
the OM (Loveless and Saier, 1997; Henderson et al., 1998), other
studies have cast doubt on this model (Bernstein, 2007). More-
over, in the absence of a significant quantity of ATP or a proton
gradient across the OM, the molecular driving force for efficient
OM secretion remains unclear (Thanassi et al., 2005).
Molecular driving forces are integral components of diverse
cellular processes, including transport of cargo along microtu-
bules by kinesin, the separation of double-stranded nucleic
acid structures, and the unfolding of substrate proteins prior to
their degradation (Zolkiewski, 2006; Enemark and Joshua-Tor,
2008; Zhang et al., 2009; Martin et al., 2010; Myong and Ha,
2010). In each of these examples, molecular motors use the
chemical energy of ATP hydrolysis to produce an asymmetrical
conformational change, which is used to produce a mechanical
force. Similarly, ions and small molecules can be concentrated
inside cells by symporters, which use the release of an electro-
chemical potential as the energy source to drive gated confor-
mational changes (Abramson and Wright, 2009; Krishnamurthy
et al., 2009). But given that there is essentially no ATP nor
a proton gradient available to drive secretion across the OM, it
is currently unclear how directed motion of AT passengers
across the OM is achieved.
It is now clear that AT secretion is facilitated by the highly
conserved and essential outer membrane protein BamA (Voul-
houx et al., 2003; Jain and Goldberg, 2007; Ieva and Bernstein,
2009; Sauri et al., 2009), which is known to facilitate insertion
of many integral outer membrane protein (OMP) domains into
the OM. It is still unclear, however, whether AT proteins rely on
BamA and/or other host proteins for porin domain insertion–296, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 287
Figure 1. Structural Organization of AT Passenger Domains and
DHFR
(A–C) Crystal structure of hemoglobin protease passenger (PDB ID: 1WXR),
a homolog of Pet (26% identical, 43% similar) (A), E. coli dihydrofolate
reductase (PDB ID: 7DFR) (B), and pertactin passenger (PDB ID: 1DAB) (C).
The stable core structures of Pet and pertactin are shown in blue, with other
b-helical structure in green. Regions associated with function (Pet protease
domain and proposed pertactin integrin binding loop) are shown in red, and
other non-b-helical structure is in yellow.
(D) Schematic representation of the sizes of passenger domain structures and
C-terminal stable cores for constructs expressed in this study. The N-terminal
signal sequence and C-terminal 30 kDa b-domain porin of each preprotein
construct are indicated by dashed lines.
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the transport of the AT passenger across the OM. Defining the
contributions of these proteins to passenger transport across
the OM in vivo is challenging, in part due to their broad substrate
specificities and overlapping functional roles (Sklar et al., 2007).
As an alternative approach, here we directly test the role of the
AT passenger itself in OM secretion by investigating the con-
tributions of passenger stability and folding properties to OM
secretion.
For this analysis, we used two well-studied ATs: pertactin
(from Bordetella pertussis) (Leininger et al., 1991) and plasmid-
encoded toxin (Pet, from a pathogenic strain of Escherichia
coli) (Navarro-Garcı´a et al., 2001) (Figures 1A and 1C). The
60 kDa pertactin passenger is composed entirely of b-helical
structure (Emsley et al., 1996). In contrast, the larger (100 kDa)
Pet passenger also has an N-terminal globular structure, a char-
acteristic feature of the SPATE (serine protease autotransporters288 Chemistry & Biology 19, 287–296, February 24, 2012 ª2012 Elseof Enterobacteriaceae) AT subfamily (Dutta et al., 2002; Otto
et al., 2005) and other unrelated AT passengers, including IgA
protease (Johnson et al., 2009). Despite low sequence identity,
both pertactin and Pet contain a ‘‘stable core’’ of b-helix rungs
at the C terminus of their passengers (Junker et al., 2006; Renn
and Clark, 2008). This similar structural organization, coupled
with the recent observation that pertactin OM secretion—and
extracellular folding—proceeds vectorially from C to N terminus
(Junker et al., 2009), led us to test how local stability within the AT
passenger affects its OM secretion.
RESULTS
OM Secretion of an AT Passenger Is Reduced in the
Presence of a Stabilizing, OM-Permeable Ligand
Despite the widespread appearance of b-helical structure in AT
passengers, in all AT crystal structures solved to date the active
site or functional region of themature virulence protein is located
in a non-b-helical structure or loop within 300 aa of the pas-
senger N terminus (Emsley et al., 1996; Otto et al., 2005; Gang-
wer et al., 2007; Johnson et al., 2009; van den Berg, 2010). We
systematically altered the stability of the globular N terminus of
the Pet passenger and determined the corresponding effects
on OM secretion efficiency. Initially, we attempted to perform
this analysis by mutating the endogenous Pet N-terminal pro-
tease structure, but this portion of the passenger alone is highly
aggregation-prone, which prohibited calculations of its stability
(DGfolding).
As an alternative approach, we constructed a chimeric pas-
senger that replaces the N-terminal Pet protease structure with
E. coli DHFR (Figure 1). At 18 kDa, DHFR is smaller than the
endogenous Pet protease structure (30 kDa), but its folding
properties are well characterized (Touchette et al., 1986; Jen-
nings et al., 1993). Despite replacement of 25% of the wild-
type Pet passenger with DHFR, the DHFR-Petb-helix chimera
was secreted into the extracellular milieu (Figure 2A), although
accumulation of the passenger+porin precursor in whole cell
lysates indicates that its secretion efficiency is somewhat re-
duced versus wild-type Pet. These results are consistent with
other reports of the tolerance of the AT secretion mechanism
to the transport of heterologous domains (Veiga et al., 2004;
Jong et al., 2007; Jose and Meyer, 2007; Jose, 2006). To test
the effects of DHFR folding on OM secretion of this chimera,
we first used methotrexate (MTX), an OM-permeable DHFR
inhibitor that stabilizes the DHFR native structure and binds
only to DHFR native conformations (Touchette et al., 1986).
Addition of up to 500 mM MTX to the culture medium had no
effect on cell growth or OM secretion of wild-type Pet (Figure 2A),
but produced a dose-dependent reduction in OM secretion of
the chimera, as measured by the reduced extracellular accumu-
lation of the processed passenger in culture media (Figure 2B;
Figure S1A available online). Concomitantly, a band correspond-
ing to a protein the size of the chimera precursor was enhanced
byMTX addition (Figure 2A). BecauseMTX can cross the OMbut
not IM, and binds selectively to the DHFR native structure
(Touchette et al., 1986), these results are consistent with MTX-
induced stabilization of the DHFR native structure within the peri-
plasm and a resulting blockade of OM secretion of the DHFR-
Petb-helix chimera. Consistent with this model, a destabilizedvier Ltd All rights reserved
Figure 2. DHFR Stabilization by Methotrexate Blocks OM Secretion of DHFR-Petb-Helix
(A) Methotrexate (MTX) does not inhibit secretion of wild-type Pet into the spent media (>100 kDa band, left), but does reduce secretion of DHFR-Petb-helix
chimera (<100 kDa band, middle). A band corresponding to the unprocessed DHFR-Petb-helix precursor is detectable in whole cell lysates (130 kDa, closed
circle, right); moreover, in the presence of MTX, a band corresponding to the size of the DHFR chimera periplasmic precursor was detected in whole cell
lysates (open circle, right). Western blot visualized using an anti-Pet polyclonal antibody; note that removal of the Pet protease domain deletes some pAb
binding epitopes in the DHFR-Petb-helix passenger (Renn and Clark, 2008), which prevents direct comparison of band intensity to that of wild-type Pet
passenger.
(B) OM secretion of the DHFR-Petb-helix chimera is inhibited by MTX in a dose-dependent manner. Black circles: chimera bearing wild-type DHFR. Red
diamonds: chimera bearing DHFR-I155A, which reduces the stability of DHFR (Table S1), requires higher concentrations of MTX to block secretion. Error bars
represent the SD of three independent experiments.
(C) E. coli cultures were preincubated with fluorescein-labeled MTX before expression of uncleavable mutants of DHFR-Petb-helix (N1018G/N1019I; Navarro-
Garcı´a et al., 2001), or the empty vector. MTX-FL stabilizes DHFR in the periplasm, blocking OM secretion of the passenger N terminus and rendering MTX-FL
inaccessible to an OM impermeable quencher. Conversely, DHFR mutant I155A is destabilized, which increases its OM secretion efficiency (Figure 4), and
enables quenching of MTX-FL bound to DHFR at the cell surface. Left panel, bright field images of E. coli bearing the indicated expression plasmid. Right panel,
fluorescein fluorescence images of the same field. Scale bar represents 5 mm. See also Figure S1.
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trations of MTX to produce a similar blockade of OM secretion
(Figure 2B). These results agree well with studies of other ATs
showing that OM secretion can be blocked by ligand binding-
induced passenger stabilization (Jong et al., 2007) or the forma-
tion of a long disulfide-bonded loop in the periplasm (Junker
et al., 2009). Moreover, these results provide clear evidence
that DHFR can fold to its native structure in the context of this
chimera. Interestingly, however, the reduction of secretion effi-
ciency for the DHFR chimera reached a plateau at 30%, rather
than 0%, suggesting that although MTX-induced stabilization
of the passenger N terminus can significantly reduce OM secre-
tion efficiency, a complete blockade could require either addi-
tional stability and/or alteration of other factors not related to
passenger domain N-terminal stability.
To confirm the location (periplasmic versus extracellular) of
DHFR in these secretion stalled chimera constructs, we used
fluorescently labeled methotrexate (MTX-FL), which also blocks
OM secretion of the chimera (Figure S1B). We incubated E. coliChemistry & Biology 19, 287with MTX-FL, then expressed a DHFR-Petb-helix construct
mutated to inhibit autocatalytic cleavage of the passenger from
its C-terminal porin (Navarro-Garcı´a et al., 2001); this mutant is
transported to the cell surface, but retained there. After expres-
sion, we tested the accessibility of DHFR-bound MTX-FL to an
antifluorescein antibody that quenches fluorescein fluorescence
and is too bulky (150 kDa) to diffuse across the OM. We hy-
pothesized that if DHFR is retained within the periplasm, the
fluorescence of the bound MTX-FL will be quenched to a lesser
extent than for DHFR-MTX-FL exposed on the cell surface. Fig-
ure 2C shows that MTX-FL fluorescence in the presence of the
uncleavable chimera bearing wild-type DHFR is unaffected by
the addition of quencher (two-tailed t test; p = 0.09; of 80 total
cells observed in 10 fields, 68 [85%] were detectably fluorescent
in the absence of quencher; of 94 total cells [in four fields]
observed in the presence of quencher, 77 [82%] were fluo-
rescent). The inability of the quencher to reduce MTX-FL fluo-
rescence indicates that the majority of the DHFR-MTX-FL is
protected within the periplasm. As a control, we also expressed–296, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 289
Figure 3. OM Secretion of DHFR-Petb-Helix Is Dependent on the
Stability of DFHR
The amount of secreted protein was detected in the spent culture media using
an anti-Pet passenger polyclonal antibody, normalized to wild-type DHFR
(green), and plotted versus the free energy of unfolding of the DHFR domain
(measured previously) (Perry et al., 1987; Garvey and Matthews, 1989; Arai
et al., 2003; see also Table S1). The double mutation with DGfolding > 0 kJ/mol
(Figure S1A) is shown in red; the red arrow indicates DGfolding > 0 kJ/mol. The
linear fit (line) resulted in R = 0.83. For comparison, secretion of PetDprotease,
which lacks an N-terminal globular domain, is represented as a horizontal blue
line. Error bars represent the SD of at least four replicates. See also Figure S2.
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Folding Properties Control Virulence Protein Secretiona noncleavable version of the destabilized DHFR-I155A chimera,
which is very efficiently secreted (see below), even in the pres-
ence of low concentrations of MTX (Figure 2B). MTX-FL fluores-
cence is efficiently quenched in the presence of this destabilized,
efficiently secreted chimera (Figure 2C; of 85 total unquenched
cells in six fields, 75 [88%] were detectably fluorescent, but in
the presence of quencher only one of 58 [2%] total cells in five
fields was fluorescent; p < 0.0001). These results confirm that
folded DHFR, stabilized by binding to MTX, is retained within
the periplasm.
OMSecretion of DHFR-Petb-Helix Is Linearly Correlated
with DHFR Stability
If stabilization of the N-terminal DHFR can block OM secretion of
the chimera, we wondered whether reducing DHFR stability
would enhance OM secretion. A number of point mutants with
a wide range of effects on DHFR stability and folding properties
have been characterized (Table S1) (Perry et al., 1987; Garvey
and Matthews, 1989; Arai et al., 2003). When introduced into
the DHFR-Petb-helix chimera, mutations that destabilize DHFR
led to increased OM secretion and processing of the chimera
(Figure 3). Conversely, point mutations that stabilize DHFR led
to reduced OM secretion and processing (Figure 3), analogous
to the effect observed upon addition of MTX. Overall, altering
passenger domain N-terminal stability produced a linearly corre-
lated (R = 0.83) change in OM secretion efficiency. To further
test the idea that OM secretion efficiency can be controlled by
the stability of the AT passenger domain N terminus, we also de-
signed a highly destabilized F31D/I155Adoublemutant that does
not form stable structure even at 0 M urea (DGfolding > 0 kJ/mol;
see Figure S2A), as measured by pulse proteolysis (Park and290 Chemistry & Biology 19, 287–296, February 24, 2012 ª2012 ElseMarqusee, 2005). As expected, this highly destabilized mutant
is secreted to even higher levels (Figure 3), similar to a Pet
passenger variant with the N-terminal protease structure deleted
(PetDprotease; Renn and Clark, 2008). Moreover, even if the
chimera context alters the absolute stability of DHFR, because
we are comparing point mutants within the chimera context it is
unlikely that this would affect the general trend observed here.
DHFR folding kinetics are complex, but we observed a closer
correlation between OM secretion efficiency and DHFR stability
than with the rate-limiting DHFR folding or unfolding rates, or
the position of the mutation in the DHFR sequence (Figures
S2B–S2D). For some DHFRmutations, we also detected smaller
Pet chimera fragments (not shown); however, the correlation
between DHFR stability and OM secretion efficiency persisted
regardless of whether these fragments were included in the anal-
ysis (R = 0.77), or not (R = 0.83; above). Moreover, immunofluo-
rescence microscopy revealed that the more stable chimeras
are detected as punctate foci at the bacterial cell surface (Fig-
ure 4D). Analogous to the MTX-FL results above (Figure 2C),
these foci presumably represent stalled OM secretion intermedi-
ates where the C-terminal Pet b-helix portion of the passenger
has been secreted (and is accessible to the anti-Pet antibody),
but the construct is retained at the surface due to the inability
to secrete the bulky, stably folded N-terminal DHFR portion of
the passenger. In contrast, chimeras bearing less stable DHFR
variants (including wild-type DHFR) are not detectable at the
cell surface (Figures 4C and 4E), presumably due to their release
into culture media at the successful conclusion of OM secretion.
The stabilizing DHFR mutations also result in increased accu-
mulation of a band corresponding to the size of the unprocessed
chimera precursor (passenger+porin) in whole cell lysates (Fig-
ure S2E), whereas less stable DHFR variants do not produce
a detectable unprocessed band (Figure S2E). These results are
consistent with the interpretation that increased passenger
domain N-terminal stability impedes transport across the OM,
rather than an earlier step in autotransporter biogenesis. Indeed,
an identical correlation (R = 0.83) was found between DGfolding
and the fraction of protein secreted (i.e., (amount secreted)/(total
protein detected inmedia plus cells); Figure S2F). In other words,
DHFR stabilization led to increased intracellular accumulation of
unprocessed preprotein and decreased extracellular accumu-
lation of the chimera, whereas DHFR destabilization produced
the opposite result.
Destabilization of the Pertactin C-Terminal Stable Core
Dramatically Lowers OM Secretion Efficiency
To test the contributions of the folding properties of b-helical
portions of the AT passenger to OM secretion, we turned to per-
tactin, the only naturally occurring AT passenger domain known
to unfold and refold reversibly at equilibrium (Junker et al., 2006).
Similar to Pet, the pertactin passenger domain is also cleaved
from its C-terminal porin via an intramolecular cleavage reaction
within its C-terminal porin (Dautin et al., 2007), but unlike Pet, the
processed pertactin passenger domain remains tightly associ-
ated with the outer surface of the bacterial cell (Junker et al.,
2009). In vitro, the purified pertactin passenger domain unfolds
in two distinct transitions: the N-terminal half of the b-helix un-
folds with amelting temperature of 65C,whereas the C-terminal
half of the b-helix has a melting temperature of 82C (Figure 5A)vier Ltd All rights reserved
Figure 4. N-Terminally Stabilized DHFR-Petb-Helix Accumulates
at the E. coli Cell Surface
Immunofluorescence microscopy images of E. coli expressing empty vector
(A), an uncleavable PetDprotease mutant (N1018G/N1019I) that acts as
a positive control for surface display of the Pet passenger (Navarro-Garcı´a
et al., 2001) and preserves Pet epitopes recognized by the anti-Pet passenger
domain polyclonal antibody in the DHFR chimera constructs (B), DHFR-
Petb-helix (C), more stable DHFR-Petb-helix D27N (D), or less stable DHFR-
Petb-helix I155A (E). Left panel, bright field images of E. coli expressing each
construct. Right panel, corresponding Cy3 fluorescence images of the same
field. Scale bar represents 5 mm.
Figure 5. Decreasing Pertactin C-Terminal Passenger Stability, but
Not N-Terminal Stability, Reduces OM Secretion
(A) Thermal unfolding of purified wild-type pertactin passenger (filled squares),
N-terminal mutant W295F (open triangles), C-terminal single mutant L498K
(filled triangles), and the globally-destabilizing C-terminal double mutant
W423F/W440F (open circles).
(B) OM secretion of wild-type and mutant pertactin passengers. E. coli whole
cell lysates were separated by SDS-PAGE and detected using an anti-
pertactin polyclonal antibody. Relative percentages of processed pertactin
passenger (filled arrowhead) were quantified and normalized to wild-type in
each growth condition. Error bars represent the SD of three to six independent
trials. Open arrowhead: unprocessed preprotein (passenger+b-domain).
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domain to selectively destabilize either the N-terminal half of
the b-helix (W295F, destabilizing the first unfolding transition),
the C-terminal half (L498K, destabilizing the second unfolding
transition) or the entire passenger domain (W423F/W440F,
destabilizing both transitions) (Figure 5A).
We introduced the mutations described above into the gene
encoding full-length pertactin, and expressed these genes inChemistry & Biology 19, 287E. coli. This pertactin expression plasmid permits either low-level
constitutive expression (via a tac promotor) or IPTG-inducible
overexpression (Junker et al., 2009). Upon transport across the
OM wild-type pertactin is autocatalytically cleaved from the
C-terminal porin to produce the mature, extracellular passenger
domain from the larger pertactin precursor (Figure 5B) (Junker
et al., 2009). Similarly, the W295F mutation that destabilizes
only the N terminus of the passenger domain b-helix resulted in
significant extracellular accumulation of the processed pertactin
passenger domain, at levels comparable to wild-type pertactin,
regardless of growth conditions (Figure 5B). In contrast, muta-
tions that destabilize either the C-terminal stable core portion of
the passenger domain or globally destabilize the entire pas-
senger domain greatly reduced OM secretion under all growth
conditions (Figure 5B), while having no effect on IPTG-induced
production of the unprocessed pertactin precursor (Figure 5B,
white arrowhead). It is important to note that in contrast to the–296, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 291
Figure 6. The N Terminus of the Pertactin Passenger Does Not
Adopt Regular Structure
(A) Far-UV CD spectra of the entire pertactin passenger domain (triangles) and
the N-terminal segment (residues 1–334) of the passenger domain (circles).
The passenger domain spectrum has aminimum218 nm aswell as a positive
signal200 nm, typical for b sheet structure, whereas the N-terminal segment
shows no significant contribution of a-helical or b sheet structure.
(B) Fluorescence spectra of the N-terminal segment under folding (0 M
GdnHCl) and unfolding (6 M GdnHCl) conditions. The lack of significant
changes for the maximum emission wavelength or total fluorescence intensity
imply no significant structural changes in the protein upon addition of GdnHCl.
Chemistry & Biology
Folding Properties Control Virulence Protein SecretionPet chimera constructs characterized above, blocking pertactin
OM secretion under low expression conditions does not lead to
increased precursor accumulation, presumably because the
rate of degradation of these precursors in the periplasm is similar
to the rate of OM secretion. Crucially, examining pertactin secre-
tion under different growth conditions demonstrates that the
different levels of processed pertactin detected here are not
due to differences in protein production. This is most noticeable
upon the overexpression in the presence of IPTG, where the
pertactin precursor accumulates to the same level regardless
of mutation, suggesting that there are no significant differences
in expression of these constructs. Alternatively, the destabilized
pertactin passenger constructs might be successfully secreted,
but degraded at the cell surface by an extracellular protease
such as OmpT. However, we saw the same general trend of
reduced secretion and processing for destabilized pertactin
passenger constructs when they were expressed in E. coli
BL21(DE3)pLysS (ompT-; not shown). These results indicate
that, in striking contrast to the globular N-terminal domain, AT
passenger b-helix stability positively contributes to OM secre-
tion efficiency, with the stability of the C-terminal stable core
making the most dramatic contribution to secretion efficiency.
The Pertactin Passenger N Terminus Is Incapable
of Folding In Vitro
Although the pertactin passenger enters the periplasm from N to
C terminus, we have previously shown that the passenger exits
the periplasm by crossing the OM from C to N terminus (Junker
et al., 2009). This raises the question of what prevents the prema-
ture folding of the pertactin passenger N terminus upon entry into
the periplasm. We have shown that complete, native-like folding
of theentire pertactin passengerdomain is anextremely slowpro-
cess in vitro (t1/2hr), but is precededby the formationof interme-
diateswith significant b sheet structure throughout thepassenger
domain (Junker and Clark, 2010). To study the intrinsic folding
capacityof thepertactinN terminus,wedesignedaconstruct cor-
responding to the less-stableN terminusof thepassenger domain
(residues 1–334; green region in Figure 1D) (Junker et al., 2006).
In vitro, the pertactin passenger domain N terminus has ‘‘random
coil’’ spectral signatures, as measured by far-UV circular
dichroism (nocharacteristicb sheetminimumat 218nm)andfluo-
rescence emission spectroscopy (no denaturant-dependent
changes to the fluorescence spectrum) (Figure 6). These results
suggest that folding of the pertactin passenger domain is unlikely
to be initiated at the N terminus upon entry into the periplasm.
DISCUSSION
Transport of AT virulence proteins across the OM is one example
of a molecular machine that produces a driving force, or directed
motion. In comparison to undirected motion (such as Brownian
motion, arising from the thermal fluctuations that affect all
biomolecules), directed motion requires an anisotropic potential
(Astumian, 1997). The results reported here demonstrate that
AT passenger secretion across the OM is dependent on an
anisotropic distribution of stability within the passenger domain:
high stability at the passenger C-terminal b-helix facilitates OM
secretion, as does low stability at the globular N terminus. Inter-
estingly, selectively altering the stability of the N-terminal half of292 Chemistry & Biology 19, 287–296, February 24, 2012 ª2012 Elsethe passenger b-helix, aswewere able to do for pertactin, had no
significant effect on OM secretion, suggesting this region might
represent a neutral ‘‘fulcrum’’ in the anisotropic distribution of
passenger domain stability and therefore play a different role in
autotransporter function (note that for both pertactin and Pet,
sequences within the N terminus of the b-helix are known to
make functional contributions to virulence [Leininger et al.,
1991; Dutta et al., 2003]). For both pertactin and Pet, the
C terminus of the wild-type passenger domain is more stable
than the N terminus (Junker et al., 2006; Renn and Clark, 2008),
and we show here that selectively destabilizing this stable core
drastically impedes OM secretion. The correlations between
the anisotropic distribution of AT passenger stability and its
effects on OM secretion efficiency demonstrate that passenger
domain folding properties are directly connected to the mecha-
nism of OM secretion, and that AT passenger domains containvier Ltd All rights reserved
Figure 7. Model for OuterMembrane Secre-
tion of an Autotransporter (AT) Passenger
Domain
Insertion of the C-terminal AT b-domain porin is
facilitated by BamA (Jain and Goldberg, 2007; Ieva
and Bernstein, 2009), but it is currently unclear
whether BamA is involved in passenger transport
across the outer membrane (OM). The C terminus
of the passenger domain crosses the OM first
(Junker et al., 2009). In vitro, the passenger C ter-
minus is more stable than the N terminus (Junker
et al., 2006) and here we have shown that reducing
passenger domain C-terminal stability reduces
OM secretion efficiency. In contrast, destabilizing
the passenger N terminus increases OM secretion
efficiency, while stabilizing the N terminus reduces
secretion. These results indicate that localized
regions of passenger stability, specifically a C ter-
minus more stable than the N terminus, create an
anisotropic potential that might serve as an ener-
getic driving force for efficient OM secretion.
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the OM.
What is the mechanistic role for these regionalized differences
of passenger domain stability, and their effects on OM secre-
tion? We hypothesize that AT passenger domains cross the
OM by exploiting the internal anisotropy of passenger domain
stability, which enforces a direction over an otherwise direction-
less Brownian motion. In other words, placement of a folding-
competent portion of the passenger b-helical C terminus in the
extracellular milieu as part of b-domain porin insertion (Figure 7,
facilitated by BamA) could drive secretion of the passenger
domain across the OM, via a unique, ATP-independent Brow-
nian ratchet mechanism driven by the folding of the passenger
domain C terminus. In contrast to well-studied catalytic motors
driven by ATP hydrolysis (such as the mechanism by which
myosin ‘‘walks’’ along actin), each AT folding transporter is
used only once, to transport a single passenger domain. More-
over, after the passenger domain is transported across the
OM, it is typically cleaved from its C-terminal porin (often via
an intramolecular reactionwithin the porin), rendering thismotion
irreversible. Essentially, the free energy of folding provides a
‘‘pawl’’ (latch) for a Brownian ratchet, creating a folding-driven
transporter that prevents backsliding of the passenger into the
periplasm. It is also important to note that these results establish
a surprising correlation between an equilibrium state function
(DGfolding) and a nonequilibrium process (dynamic transport
through the periplasm and across the OM).
Although a few studies have reported successful OMsecretion
of folded heterologous passenger domain structures (Veiga
et al., 2004; Skillman et al., 2005) and small disulfide-bonded
loops (Jong et al., 2007), there appears to be a growing con-
sensus that formation of larger, stably folded structure within
the periplasm is incompatible with AT OM secretion (Klauser
et al., 1990; Jose et al., 1996; Jong et al., 2007; Junker et al.,
2009; Leyton et al., 2011). Results presented here demonstrate
that periplasmic folding of a globular domain at the AT passenger
N terminus reduces OM secretion efficiency. But what prevents
a wild-type AT passenger from adopting a stable structure
prematurely in the periplasm? In vivo, the passenger enters the
periplasm from N to C terminus, in contrast to OM secretion,Chemistry & Biology 19, 287which proceeds from C to N terminus (Junker et al., 2009). Our
results suggest that the pertactin N terminus is incapable of initi-
ating folding (Figure 6), which might retard the folding rate in the
periplasm. These results might explain why a recent study of OM
secretion of EspP (a homolog of Pet) reported that EspP pas-
senger domain C-terminal mutants with faster in vitro refolding
kinetics were secreted more efficiently across the OM, rather
than less (Peterson et al., 2010). Regardless of the precisemech-
anism, the environment for initiating AT passenger folding in the
periplasm (or the test tube) appears fundamentally different from
the extracellular environment and incompatible with the rapid
formation of stable structure within the AT passenger N terminus
before OM secretion.
Given that OM secretion appears to require the passenger
N terminus to maintain or adopt a destabilized conformation in
the periplasm, the crucial variables for the N-terminal domain
will be the relative stabilities of the folded and unfolded states
(DGfolding) and—remembering that the periplasm is a nonequilib-
rium system (Clark, 2004)—the rate at which the unfolded state
can be accessed from the folded state (kunf; see Figure S1C).
Of course, these variables must remain compatible with the
native state stability required for activity of themature passenger
domain (Bloom et al., 2006). Finally, although the correlation re-
ported here between regionalized AT passenger stability and
OM secretion efficiency highlights one aspect of the AT OM
secretion mechanism, it is important to note that many other
factors surrounding this mechanism remain unclear. For ex-
ample, it has been shown that small (but not large) disulfide-
bonded loops within the AT passenger can be efficiently
secreted across the OM, suggesting a limited tolerance to peri-
plasmic folding within the passenger (Jong et al., 2007; Leyton
et al., 2011). Moreover, interactions between AT OM secretion
precursors and periplasmic chaperones could further modulate
the effects observed here, for example by stabilizing unfolded
conformations of AT precursors while they transit the periplasm.
SIGNIFICANCE
Here, we modulated OM secretion efficiency by manipu-
lating the biophysical properties of the transported AT–296, February 24, 2012 ª2012 Elsevier Ltd All rights reserved 293
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of distinct regions of the AT passenger provide a directed
molecular driving force, for use as a generalized transporter
device. Strategies that alter AT passenger folding properties
might therefore be effective for combating Gram-negative
bacterial pathogenesis. In addition, the contributions of
the passenger folding properties to secretion efficiency
have significant implications for the re-engineering of the
AT secretion mechanism for transport of heterologous pro-
tein ‘‘cargo,’’ such as for in vitro protein evolution (‘‘auto-
display’’) (Jose and Meyer, 2007; Jose, 2006). In conclusion,
the regionalized distribution of AT passenger domain sta-
bility provides a unique solution for the directed transport
of macromolecules across biological membranes, sug-
gesting a new, ATP-independent category of folding-driven
transporter.
EXPERIMENTAL PROCEDURES
Molecular Biology
pET21b-PetDprotease was constructed using an approach analogous to the
one used to construct pCEFN1Dprotease (Renn and Clark, 2008). E. coli
DHFR C85A/C152S was amplified from plasmid pTZ-AS-DHFR (Iwakura
et al., 1993), using primers that included NheI overhangs. This PCR product
was ligated into the unique NheI site in pET21-PetDprotease, located between
the sequence encoding the signal sequence and the Pet passenger b-helix.
DHFR,Pet, andpertactinpointmutantswereconstructedbysite-directedmuta-
genesis. The sequence of each construct was confirmed by DNA sequencing.
Expression and Detection of Pet and Pet Chimera Constructs
All pET21b-Pet constructs were expressed in E. coli strain BL21(DE3)pLysS.
Typically, an overnight culture was prepared from a single colony in 25 ml
LB plus 100 mg ml1 of ampicillin at 37C. A total of 250 ml of this overnight
culture was diluted into 25 ml LB plus 100 mg ml1 of ampicillin and grown
to OD600 = 0.20–0.25. Expression was initiated by addition of 0.5 mM IPTG.
After 50 min, the cell culture was centrifuged at 5,0003 g for 5 min to separate
the cells from the spent media. The spent media was filtered through a
0.22 mm filter and 1.5 ml was precipitated with 20% trichloroacetic acid. The
cell pellet was resuspended in SDS gel loading buffer, and lysed by a single
freeze/thaw step. Proteins present in the media and cell fractions were
analyzed by SDS-PAGE and western blotting using an anti-Pet polyclonal
antibody as follows. Proteins were transferred to a PVDF membrane, typically
for 1 hr at 75 V in buffer containing 25 mM Tris, 192 mM glycine, and
20% methanol. Nonspecific antibody binding was reduced by incubating for
10 min with 5% powdered dry milk (PDM) in Tris-buffered saline plus
Tween-20 (TBST; 20 mM Tris pH 7.5, 150 mM NaCl and 0.5% Tween-20).
The membrane was incubated for 45 min in a solution containing an anti-Pet
passenger polyclonal antibody in 5% PDM in TBST, followed by a 30 min
incubation with a solution containing an alkaline phosphatase-conjugated
anti-rabbit secondary antibody (Novus Biologicals) in TBST containing 5%
PDM. For both the primary and secondary antibody, excess unbound antibody
was removed by three washes with TBST for 90 s each. The membrane was
washed five times with double deionized water, and bands were visualized
by incubating the membrane in nitro-blue tetrazolium chloride (NBT) and
bromo-chloro-indolyl-phosphate (BCIP) substrates (Promega) in alkaline
phosphatase (AP) buffer, typically for 5–10 min. The AP buffer contained
100 mM Tris pH 9.0, 100 mM NaCl, and 5 mM MgCl2. Blots were quantified
as described below.
Methotrexate Titration of DHFR-Petb-Helix Secretion
Methotrexate (MTX; Sigma) and fluorescein-conjugated methotrexate (MTX-
FL; Invitrogen) were prepared as 10 mg/ml and 2 mg/ml stock solutions,
respectively, in 0.1 M NaOH. Three milliliters of a log phase culture of E. coli
(OD600 = 0.2–0.25) was prepared as described above and treated with MTX
or MTX-FL to achieve the indicated range of final concentrations. Cultures294 Chemistry & Biology 19, 287–296, February 24, 2012 ª2012 Elsewere incubated with MTX (or FL-MTX) for 10 min at 37C while shaking, fol-
lowed by IPTG-induced induction of expression of DHFR-Petb-helix (bearing
either wild-type DHFR, or the destabilizing I155A mutation). Accumulation of
DHFR-Petb-helix in the spent media and whole cells was analyzed as
described above.
Quantification of Autotransporter Secretion Efficiency
Western blot band intensities for Pet passenger domain constructs were
measured by densitometry, quantified using NIH ImageJ software, and com-
pared to a standard curve of band intensities of known concentrations of
purified PetDprotease. For all DFHR-Petb-helix experiments, the 100 kDa
processed passenger band, corresponding to the secreted protein, was quan-
tified from the spent media fraction. For analyzing the effect of MTX on DHFR-
Petb-helix secretion, results were normalized to 0 nM MTX (100% secretion).
For DHFR chimera mutants, the band corresponding to the DHFR-Petb-helix
passenger domain was quantified for at least four independent experiments
each mutant and normalized to the intensity of the band corresponding to
the chimera bearing the wild-type DHFR sequence; error was calculated as
the standard deviation between these measurements. To calculate secretion
efficiency as the fraction of the Pet construct that was processed and released
from the cell surface relative to all Pet construct detected (released plus cell-
associated; Figures S1E and S1F), we also quantified bands corresponding to
the unprocessed preprotein in the whole cell lysate fraction for three indepen-
dent experiments. For these experiments, secretion efficiency was calculated
as follows:
secretion efficiency =
passenger band intensity
passenger band intensity +precursor band intensity
:
Fluorescence Microscopy
For detection of MTX-FL fluorescence, 500 ml of a log-phase culture of E. coli
BL21(DE3)pLysS transformed with empty vector or a plasmid encoding a
DHFR-Petb-helix construct was incubated with FL-MTX (1 nM final concentra-
tion) for 10 min. Protein expression was induced by addition of IPTG to a final
concentration of 0.5 mM, followed by 30 min incubation at 37C. Cells were
harvested by centrifugation at 1,000 3 g for 5 min, washed twice with phos-
phate buffered saline (PBS) to remove excess, unbound FL-MTX. Resus-
pended cells were diluted 5-fold, and divided into two groups of 500 ml
aliquots. To one group, 5 ml of the antifluorescein quencher (antifluorescein/
Oregon Green rabbit IgG; Invitrogen) was added. To the other group, 5 ml of
PBS was added. Aliquots were incubated for 20 min in the dark, after which
cells were immobilized on poly-L-lysine-coated coverslips for 20 min. Cover-
slips were washed twice with PBS to remove unbound quencher. Microscopy
images were collected using an Applied Precision DeltaVision Core fluores-
cence microscope, using identical conditions for each construct (1.42 numer-
ical aperture, 1003 objective, and 40 ms exposure time). The fluorescence
images were deconvolved using constrained iterative deconvolution. For the
quantification, the total number of cells visible in the bright field image was
counted for each field, and the number of detectably fluorescent cells was
expressed as a percentage of this total. There was no significant difference
in fluorescence of unquenched cells expressing either the wild-type DHFR
or DHFR-I155A chimera (p = 0.158).
For immunofluorescence detection of DHFR-Petb-helix localization, log-
phase cell cultures of E. coli BL21(DE3)pLysS expressing different DHFR-
Petb-helix constructs, a noncleavable PetDprotease mutant (N1018G/
N1019I), or the empty vector were induced for 30 min, harvested by centrifu-
gation at 1,000 3 g for 5 min, resuspended in PBS, and washed twice
with PBS to remove secreted, cleaved Pet passenger constructs. Resus-
pended cells were placed on poly-L-lysine coated coverslips, followed by
a 10 min incubation with the anti-Pet polyclonal antibody and a 10 min
incubation with a Cy3 conjugated anti-rabbit secondary antibody (Jackson
ImmunoResearch Labs, West Grove, PA). Each antibody incubation was
preceded by three washes with PBS; prior to imaging, three final washes
were performed. Images were collected as described above.
Pertactin Expression and Quantification
Pertactin passenger domain expression, purification, and optical spectra
(far-UV circular dichroism and tryptophan fluorescence) were performed andvier Ltd All rights reserved
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Expression and extracellular secretion of full-length pertactin and its mutants
was performed in E. coli HB101 as previously described (Junker et al., 2009)
with the exception that normalized whole cell lysates were analyzed instead
of purified OM fractions. SDS-PAGE and western blotting and development
were performed as described above for Pet, using an antipertactin polyclonal
antibody. For wild-type pertactin and each mutant, antipertactin western blot
bands corresponding to the 60 kDa extracellular processed passenger domain
(closed arrowhead in Figure 5B) were quantified using the public domain NIH
ImageJ program. Secretion of wild-type pertactin, as measured by the inten-
sity of the processed passenger, was set at 100%. Secretion of the mutant
pertactin constructs is expressed as a percentage of wild-type pertactin
secretion.
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